Boldenone undecylenate: Difference between revisions
CSV import |
CSV import |
||
| Line 22: | Line 22: | ||
[[Category:Controlled substances]] | [[Category:Controlled substances]] | ||
{{pharma-stub}} | {{pharma-stub}} | ||
{{No image}} | |||
Revision as of 07:58, 10 February 2025
Boldenone undecylenate is an anabolic steroid developed for veterinary use, mostly for treatment of horses. It is not indicated for use in humans in the United States and is only available through veterinary clinics.
History
Boldenone undecylenate was first synthesized in the 1950s by Ciba, a Swiss pharmaceutical company. It was developed as a long-acting injectable methandrostenolone (Dianabol), but in practice it does not have this effect.
Medical uses
Boldenone undecylenate is used in veterinary medicine, primarily in horses. It is used to improve physique and performance. The drug is also used in cattle to enhance growth.
Side effects
Like other anabolic steroids, boldenone undecylenate can have a number of side effects, including acne, hair loss, increased aggression, and gynecomastia. It can also have serious effects on the cardiovascular system, including hypertension and atherosclerosis.
Legal status
In the United States, boldenone undecylenate is classified as a Schedule III controlled substance under the Controlled Substances Act. It is also banned by many sporting organizations, including the International Olympic Committee.
